Schroder Investment Management Group’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $574M | Buy |
2,280,159
+63,874
| +3% | +$13.7M | 0.41% | 45 |
|
|
2026
Q1 | $472M | Sell |
2,216,285
-987,081
| -31% | -$219M | 0.39% | 52 |
|
|
2025
Q4 | $732M | Buy |
3,203,366
+395,029
| +14% | +$90M | 0.55% | 34 |
|
|
2025
Q3 | $650M | Buy |
2,808,337
+243,666
| +10% | +$49.6M | 0.51% | 38 |
|
|
2025
Q2 | $476M | Sell |
2,564,671
-176,770
| -6% | -$32.9M | 0.4% | 54 |
|
|
2025
Q1 | $574M | Buy |
2,741,441
+315,336
| +13% | +$61.3M | 0.58% | 35 |
|
|
2024
Q4 | $431M | Sell |
2,426,105
-235,739
| -9% | -$43.3M | 0.41% | 55 |
|
|
2024
Q3 | $526M | Buy |
2,661,844
+568,539
| +27% | +$106M | 0.54% | 36 |
|
|
2024
Q2 | $359M | Buy |
2,093,305
+227,534
| +12% | +$37.7M | 0.4% | 54 |
|
|
2024
Q1 | $340M | Sell |
1,865,771
-27,760
| -1% | -$4.78M | 0.4% | 54 |
|
|
2023
Q4 | $293M | Buy |
1,893,531
+60,942
| +3% | +$8.88M | 0.38% | 55 |
|
|
2023
Q3 | $273M | Buy |
1,832,589
+362,449
| +25% | +$53.2M | 0.41% | 53 |
|
|
2023
Q2 | $198M | Buy |
1,470,140
+41,628
| +3% | +$6.1M | 0.28% | 69 |
|
|
2023
Q1 | $228M | Sell |
1,428,512
-111,087
| -7% | -$17M | 0.34% | 64 |
|
|
2022
Q4 | $249M | Sell |
1,539,599
-358,076
| -19% | -$54.9M | 0.4% | 51 |
|
|
2022
Q3 | $255M | Sell |
1,897,675
-116,660
| -6% | -$16.7M | 0.42% | 52 |
|
|
2022
Q2 | $310M | Buy |
2,014,335
+227,618
| +13% | +$34.8M | 0.47% | 41 |
|
|
2022
Q1 | $293M | Sell |
1,786,717
-503,947
| -22% | -$73.2M | 0.39% | 57 |
|
|
2021
Q4 | $310M | Buy |
2,290,664
+289,498
| +14% | +$34.2M | 0.41% | 53 |
|
|
2021
Q3 | $216M | Buy |
2,001,166
+210,677
| +12% | +$24.1M | 0.33% | 61 |
|
|
2021
Q2 | $202M | Sell |
1,790,489
-35,634
| -2% | -$4.01M | 0.25% | 81 |
|
|
2021
Q1 | $198M | Buy |
1,826,123
+103,972
| +6% | +$11.1M | 0.26% | 82 |
|
|
2020
Q4 | $185M | Sell |
1,722,151
-217,705
| -11% | -$20.9M | 0.26% | 81 |
|
|
2020
Q3 | $167M | Sell |
1,939,856
-69,980
| -3% | -$6.59M | 0.27% | 82 |
|
|
2020
Q2 | $197M | Sell |
2,009,836
-284,160
| -12% | -$25M | 0.36% | 58 |
|
|
2020
Q1 | $174M | Sell |
2,293,996
-477,402
| -17% | -$40.7M | 0.37% | 56 |
|
|
2019
Q4 | $245M | Sell |
2,771,398
-1,302,639
| -32% | -$108M | 0.4% | 51 |
|
|
2019
Q3 | $305M | Buy |
4,074,037
+738,176
| +22% | +$50.6M | 0.54% | 40 |
|
|
2019
Q2 | $243M | Buy |
3,335,861
+8,049
| +0.2% | +$633K | 0.44% | 48 |
|
|
2019
Q1 | $268M | Buy |
3,327,812
+646,051
| +24% | +$52.9M | 0.48% | 49 |
|
|
2018
Q4 | $247K | Buy |
2,681,761
+324,587
| +14% | +$28.5M | 0.45% | 41 |
|
|
2018
Q3 | $223M | Sell |
2,357,174
-122,786
| -5% | -$11.6M | 0.38% | 59 |
|
|
2018
Q2 | $229M | Buy |
2,479,960
+451,903
| +22% | +$44.1M | 0.4% | 52 |
|
|
2018
Q1 | $192M | Sell |
2,028,057
-15,839
| -0.8% | -$1.74M | 0.33% | 68 |
|
|
2017
Q4 | $198M | Sell |
2,043,896
-156,890
| -7% | -$14.8M | 0.32% | 65 |
|
|
2017
Q3 | $196M | Sell |
2,200,786
-1,254,672
| -36% | -$95.5M | 0.34% | 60 |
|
|
2017
Q2 | $250M | Sell |
3,455,458
-214,262
| -6% | -$14.4M | 0.45% | 41 |
|
|
2017
Q1 | $240M | Buy |
3,669,720
+386,943
| +12% | +$24.3M | 0.43% | 41 |
|
|
2016
Q4 | $206M | Buy |
3,282,777
+328,433
| +11% | +$20M | 0.39% | 52 |
|
|
2016
Q3 | $186M | Buy |
2,954,344
+2,021,049
| +217% | +$131M | 0.35% | 61 |
|
|
2016
Q2 | $57.8M | Buy |
933,295
+364,843
| +64% | +$22.2M | 0.12% | 218 |
|
|
2016
Q1 | $32.4M | Buy |
568,452
+333,858
| +142% | +$18.6M | 0.07% | 344 |
|
|
2015
Q4 | $13.9M | Sell |
234,594
-282,743
| -55% | -$16.3M | 0.03% | 560 |
|
|
2015
Q3 | $28.1M | Sell |
517,337
-203,688
| -28% | -$13.3M | 0.06% | 369 |
|
|
2015
Q2 | $48.4M | Sell |
721,025
-3,972,594
| -85% | -$259M | 0.1% | 278 |
|
|
2015
Q1 | $271M | Buy |
4,693,619
+1,321,645
| +39% | +$79.8M | 0.53% | 34 |
|
|
2014
Q4 | $221M | Sell |
3,371,974
-653,633
| -16% | -$41.2M | 0.43% | 52 |
|
|
2014
Q3 | $233M | Sell |
4,025,607
-761,812
| -16% | -$42.3M | 0.31% | 67 |
|
|
2014
Q2 | $270M | Sell |
4,787,419
-329,190
| -6% | -$17.3M | 0.34% | 54 |
|
|
2014
Q1 | $263M | Buy |
5,116,609
+851,329
| +20% | +$43M | 0.3% | 63 |
|
|
2013
Q4 | $225M | Sell |
4,265,280
-1,095,014
| -20% | -$53.8M | 0.28% | 66 |
|
|
2013
Q3 | $240M | Buy |
5,360,294
+657,870
| +14% | +$29.2M | 0.58% | 30 |
|
|
2013
Q2 | $194M | Buy |
+4,702,424
| New | +$206M | 0.51% | 38 |
|
Other funds holding ABBV
Schroder Investment Management Group's ABBV Position: Q2 2026 in Review
Schroder Investment Management Group increased its AbbVie (ABBV) stake by 2.9% in Q2 2026, buying an estimated $13.7M and bringing the position to 2,280,159 shares worth $574M. The position accounts for 0.41% of the portfolio, ranked #45.
Schroder Investment Management Group first reported a position in ABBV in Q2 2013 and has held it in 53 quarters since. The position peaked at $732M in Q4 2025. 4,187 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.
- Schroder Investment Management Group held 2,280,159 shares of AbbVie worth $574M as of Q2 2026.
- Schroder Investment Management Group bought 63,874 AbbVie shares in Q2 2026, an estimated $13.7M.
- AbbVie made up 0.41% of Schroder Investment Management Group's portfolio in Q2 2026, its #45 holding.
- Schroder Investment Management Group first reported a position in AbbVie in Q2 2013 and has held it in 53 quarters since.
- Schroder Investment Management Group's AbbVie position peaked at $732M in Q4 2025.
- 4,187 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.
Based on Schroder Investment Management Group's 13F filing for Q2 2026, filed 13 Aug 2026.